These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34371741)

  • 1. Innovating on Inhaled Bioequivalence: A Critical Analysis of the Current Limitations, Potential Solutions and Stakeholders of the Process.
    Gallegos-Catalán J; Warnken Z; Bahamondez-Canas TF; Moraga-Espinoza D
    Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of regulations for bioequivalence assessment of locally acting orally inhaled drug products for the United States, Europe, Canada, and India.
    Patil PP; Pawar AP; Mahadik KR; Gaikwad VL
    Expert Opin Drug Deliv; 2021 Dec; 18(12):1843-1855. PubMed ID: 34814778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Essentialities in Establishing the Bioequivalence of Oral Inhalation Drug Products to be Marketed in the USA.
    Fernandes SD; Koland M
    Ther Innov Regul Sci; 2020 Jul; 54(4):738-748. PubMed ID: 32557296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations for the Forced Expiratory Volume in 1 Second-Based Comparative Clinical Endpoint Bioequivalence Studies for Orally Inhaled Drug Products.
    Lee J; Feng K; Conti DS; Walenga R; Wientjes M; Wang H; Newman B; Han L; Dhapare S; Bielski E; Babiskin A; Wu F; Donnelly M; Kim MJ; Jiang W; Luke MC; Fang L; Zhao L
    Clin Pharmacol Ther; 2022 Nov; 112(5):982-989. PubMed ID: 35133652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policy of Multisource Drug Products in Latin America: Opportunities and Challenges on the Application of Bioequivalence In Vitro Assays.
    Miranda-Pérez de Alejo C; Aceituno Álvarez A; Mendes Lima Santos G; Fernández Cervera M; Jung-Cook H; Cabrera-Pérez MÁ
    Ther Innov Regul Sci; 2021 Jan; 55(1):65-81. PubMed ID: 32602028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products.
    Newman B; Witzmann K
    Pharmaceut Med; 2020 Apr; 34(2):93-102. PubMed ID: 32112304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing bioequivalence for inhaled drugs; weighing the evidence.
    Daley-Yates PT; Parkins DA
    Expert Opin Drug Deliv; 2011 Oct; 8(10):1297-308. PubMed ID: 21699442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences.
    Lu D; Lee SL; Lionberger RA; Choi S; Adams W; Caramenico HN; Chowdhury BA; Conner DP; Katial R; Limb S; Peters JR; Yu L; Seymour S; Li BV
    AAPS J; 2015 May; 17(3):546-57. PubMed ID: 25758352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: Naproxen.
    Loisios-Konstantinidis I; Cristofoletti R; Fotaki N; Turner DB; Dressman J
    Eur J Pharm Sci; 2020 Feb; 143():105170. PubMed ID: 31783158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence Common Deficiencies in Generic Products Submitted for Registration to the South African Health Products Regulatory Authority (SAHPRA).
    Moeti L; Litedu M; Joubert J
    Ther Innov Regul Sci; 2022 Sep; 56(5):822-838. PubMed ID: 35896784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence study of ipratropium bromide inhalation aerosol using PBPK modelling.
    Zhang J; Wu K; Liu B; Hou S; Li X; Ye X; Liu J; He Q
    Front Med (Lausanne); 2023; 10():1056318. PubMed ID: 36824609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory Approaches and Considerations in Establishing Bioequivalence of Inhaled Compounds.
    Mayers I; Bhutani M
    J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):18-24. PubMed ID: 28708443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory Considerations for Approval of Generic Inhalation Drug Products in the US, EU, Brazil, China, and India.
    Lee SL; Saluja B; García-Arieta A; Santos GM; Li Y; Lu S; Hou S; Rebello J; Vaidya A; Gogtay J; Purandare S; Lyapustina S
    AAPS J; 2015 Sep; 17(5):1285-304. PubMed ID: 26002510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculating the Charcoal Blockade Efficiency for Bioequivalence Study of Inhaled Ipratropium Bromide Using A Model Method.
    Cheng Y; Zhou X; Wang Z; He G; Yang L; Hou S
    J Pharm Sci; 2022 Jul; 111(7):2107-2115. PubMed ID: 35257696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an Aerosol Dose Collection Apparatus for In Vitro Dissolution Measurements of Orally Inhaled Drug Products.
    Price R; Shur J; Ganley W; Farias G; Fotaki N; Conti DS; Delvadia R; Absar M; Saluja B; Lee S
    AAPS J; 2020 Feb; 22(2):47. PubMed ID: 32060670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence of Two Tiotropium Dry Powder Inhalers and the Utility of Realistic Impactor Testing.
    Gobetti C; Dissanayake S; Shur J; Ganley W; Silva L; Salem I; Najib O; Harb U
    J Aerosol Med Pulm Drug Deliv; 2023 Oct; 36(5):257-267. PubMed ID: 37358626
    [No Abstract]   [Full Text] [Related]  

  • 19. iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products.
    Hastedt JE; Bäckman P; Cabal A; Clark A; Ehrhardt C; Forbes B; Hickey AJ; Hochhaus G; Jiang W; Kassinos S; Kuehl PJ; Prime D; Son YJ; Teague S; Tehler U; Wylie J
    Mol Pharm; 2024 Jan; 21(1):164-172. PubMed ID: 38059771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new hypothesis to investigate bioequivalence of pharmaceutical inhalation products.
    Khoubnasabjafari M; Rahimpour E; Samini M; Jouyban-Gharamaleki V; Chen L; Chen D; Chan HK; Jouyban A
    Daru; 2019 Jun; 27(1):517-524. PubMed ID: 30847847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.